Skip to main content
Equibles

Balyasny Asset Management L.P.

Position in HAE — Haemonetics Corp

CIK 1218710 Chicago, IL
Back to HAE Full portfolio

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,123,575
+$8,614,752 QoQ
Shares Held
134,981
+617.0% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 329 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. HAE ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PEN
Penumbra Inc
 1,090,163 $344,218,967
2 MDT
Medtronic plc
 986,367 $77,163,489
3 GKOS
GLAUKOS Corp
 491,636 $68,711,047
4 ABT
Abbott Laboratories
 740,808 $67,220,917
5 EW
Edwards Lifesciences Corp
 456,202 $41,268,032
6
739,829 $18,406,945
7 BBNX
Beta Bionics, Inc.
 855,682 $13,408,536
8 AXGN
Axogen, Inc.
 253,498 $11,709,072

All Filings in HAE

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,123,575 134,981
2025-12-31 $1,508,823 18,825
2025-09-30 $15,702,712 322,173
2024-12-31 $3,845,440 49,250
2024-03-31 $7,739,025 90,674
2023-12-31 $3,928,841 45,946
2023-06-30 $4,659,967 54,733
2023-03-31 $12,657,605 152,962
2022-09-30 $18,039,408 243,677
2022-06-30 $35,632,341 546,676
2021-12-31 $18,835,936 355,127
2021-09-30 $24,058,201 340,816
2021-06-30 $808,609 12,134
2020-12-31 $19,587,100 164,944
2020-09-30 $22,861,245 262,020
2020-06-30 $11,322,533 126,424